• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Radiation Therapy Services Announces Michael Steinberg, M.D. And Paul Wallner, D.O. Selected to Become Fellows of the American Society for Therapeutic Radiology and Oncology

Posted on: Tuesday, 12 September 2006, 18:01 CDT

FORT MYERS, Fla., Sept. 12 /PRNewswire-FirstCall/ -- Radiation Therapy Services, Inc. , a leading operator of radiation therapy centers, announced today that Senior Vice Presidents Michael Steinberg, M.D. and Paul Wallner, D.O., have been selected to become Fellows of the American Society for Therapeutic Radiology and Oncology (ASTRO). Drs. Steinberg and Wallner will receive their FASTRO designation on November 5 at a special ceremony during the Society's 48th Annual Meeting scheduled for November 5-9, 2006 in Philadelphia.

Dr. Steinberg is the Chair of the Health Policy Council for ASTRO and sits on its Board of Directors. Dr. Steinberg is ASTRO's representative to the American Medical Association's (AMA) CPT Editorial Panel, which defines the nomenclature for medical procedures. He has been instrumental in providing meaningful input into critical health policy and economic issues on behalf of patients and the specialty through his various leadership positions in radiation oncology. In addition to his leadership roles in healthcare economics, Dr. Steinberg serves as the Principle Investigator of a National Cancer Institute sponsored project to improve outcomes in medically underserved patients. He currently also serves as the ASTRO representative to the American Medical Association's (AMA) CPT Editorial Panel and on the ASTRO Board of Directors.

Dr. Wallner was the first and only member of ASTRO to sit on the AMA/Specialty Society Relative Value System Update Committee (RUC) and the first ASTRO member to sit on the Center for Medicare & Medicaid Services Ambulatory Payment Classification Advisory Committee providing recommendations on hospital outpatient reimbursement codes, levels of reimbursement for hospital-based technical services and new technology utilization. He also served as the ASTRO representative to the AMA CPT Editorial Panel. Dr. Wallner was previously a member of the ASTRO Board of Directors and the American College of Radiology (ACR) Board of Chancellors. He is currently a member of the American College of Radiation Oncology (ACRO) Board of Chancellors. He is also a recipient of ASTRO's Gold Medal, the highest honor that can be bestowed on a member of the Society.

Dr. Daniel Dosoretz, President and Chief Executive Officer, said, "We congratulate Drs. Steinberg and Wallner on their selection as Fellows of ASTRO. It is a testament to their commitment to the field of radiation oncology. Our physician quality and depth of expertise is a major competitive advantage that allows us to remain ahead of the competitive curve in the utilization of the most advanced radiation therapy technologies."

Members of ASTRO are eligible to become a Fellow after 20 years of membership, serving in a leadership role for the organization and have making a significant contribution to the field of radiation oncology. The primary pathways to becoming a Fellow are research, patient care, education and leadership/service. The Society values contributions to all four areas, however, each nominee needs to have a "truly outstanding" contribution to at least one of the pathways to be named a Fellow.

About Radiation Therapy Services

Radiation Therapy Services, Inc., which operates radiation treatment centers primarily under the name 21st Century Oncology, is a provider of radiation therapy services to cancer patients. The Company's 69 treatment centers are clustered into 23 local markets in 14 states, including Alabama, Arizona, California, Delaware, Florida, Kentucky, Maryland, Massachusetts, Nevada, New Jersey, New York, North Carolina, Rhode Island and West Virginia. The Company is headquartered in Fort Myers, Florida. More information about the Company can be found at its Web site http://www.rtsx.com/. RTSXG

This release may contain forward-looking statements about the Company's future plans, expectations and objectives. Words such as "may,""will,""expect,""intend,""anticipate,""plan,""believe,""seek,""could" and "estimate" and variations of these words and similar expressions are intended to identify forward-looking statements. These forward-looking statements are not historical facts and are subject to risks and uncertainties that could cause the actual results to differ materially from those projected in these forward-looking statements including, but not limited to those risk factors described in the "Risk Factors" section and other information in the Company's most recently filed quarterly report on Form 10-Q and annual report on Form 10-K, as well as the Company's other filings with the Securities and Exchange Commission which are available on the SEC's website at http://www.sec.gov/. Readers of this release are cautioned not to place undue reliance on forward-looking statements. The Company undertakes no obligation to publicly update or revise the forward-looking statements contained herein to reflect changed events or circumstances after the date of this release.

Contacts: Dave Koeninger Chief Financial Officer Radiation Therapy Services, Inc. 239-931-7282 dkoeninger@rtsx.com Investors/Media: Nick Laudico/Jason Rando The Ruth Group 646-536-7030/7025 nlaudico@theruthgroup.com jrando@theruthgroup.com

Radiation Therapy Services, Inc.

CONTACT: Dave Koeninger, Chief Financial Officer of Radiation TherapyServices, Inc., +1-239-931-7282, dkoeninger@rtsx.com; or Investors, NickLaudico, +1-646-536-7030, nlaudico@theruthgroup.com, or Media, Jason Rando,+1-646-536-7025, jrando@theruthgroup.com, both of The Ruth Group, forRadiation Therapy Services, Inc.

Web site: http://www.rtsx.com/

Source: PRNewswire-FirstCall

More News in this Category